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                                               ABSTRACT 
BACKGROUND: 
                Aim of this study is to know the prevalence of hyperglycemia in OPC 
 poisoning ,to know the prevalence of pancreatitis in OPC poisoning  and  to  
find the association of hyperglycemia and elevated pancreatic enzyme level. 
STUDY METHOD: 
                The study was conducted in Tirunelveli medical college,intensive  
medical care unit in 100 patients who consumed OPC, excluding alcoholic, 
diabetic,patients who underwent pancreatic procedures.It is a cross-sectional  
study.In this  study  serum amylase  is compared with  variables such as age,sex, 
vitals,compound,amount,blood sugar, WBC,PCV,lipase.The results  were  
analysed  and  interpreted  using  software by statistician. 
CONCLUSION: 
           Among 100 patients studied , serum amylase were elevated in 6 patients. 
Serum lipase were elevated in 6 patients. Blood sugar were elevated in 10  
patients.Among patients with  hyperamylasemia  only 2%  have  elevated blood 
sugar.So, correlation  between blood sugar and serum amylase still have to be 
 studied.Hyperglycemia  in OPC  is due to initial hypoglycemia or due to 
pancreatic insufficiency.In  our study their relation is not statistically 
 significant. 
KEYWORD: 
OPC,pancreatitis, amylase,lipase,blood sugar. 
 
           
       
 
 
                                                      INTRODUCTION 
A poison is a substance which on inhalation, ingestion, or with direct contact  produces  
 deleterious or harmful effect on human being. 
POISONING: 
Accidental and suicidal poisoning  remains  the major worldwide problem  which results in 
  significant annual morbidity and mortality.. In general,decontamination followed by  
supportive care  has been regarded as essentials of  clinical poisoning management. However  
in certain circumstances  specific antidotes  reduce the, morbidity and mortality and duration  
of hospitalisation. 
Establishment of toxicology response centre is a emerging need  in India. Antidotes were  
considered essential  and necessary within the first hour of patient presentation .The quantity 
 of  antidote  recommended is based on the dose necessary to treat  one or two 70 kg man.As 
 per BAEM ( british association of emergency medicine) guidelines for stocking the 
 antidotes should be divided   on the basis of immediate availability and andidotes that 
 should be available  within 4 hours of  admission. 
OPC POISONING: 
    Organophosphorus compound(OPC) is commonly available in almost all parts of 
India.It kills  an estimated population of 200 000 people every year. Commonly consumed  
organophosphorus compound in this part of state are monocrotophos,  propophenos, and  
dimethoate.Each of these compounds have different toxicity  index so that their lethal dose  
varies. Each of these compound known to produce  complications  other  than usual  features  
suggestive of  cholinergic  action on  muscarinic and nicotinic receptors. Usually these  
patients admitted in intensive medical care  unit with neurological and respiratory symptoms.  
 Pancreatitis is a known but rare complication , often goes unrecognised. So, high  suspicious  
eye  is essential to identify these patients presenting with  unexplained hemodynamic 
instability. 
              Metabolic complications such as hyperglycemia, diabetic Ketoacidosis have to be  
kept in mind.There are certain scales to assess the need for mechanical ventilation, dose of  
atropine called peradineya scale which is based on features such as, miosis,bradycardia  
respiration,fasciculation and level of consciousness. In this study  I am going to correlate the  
association of   blood sugar with  pancreatic enzyme levels. 
AIM & OBJECTIVE: 
 To know the prevalence of hyperglycemia in OPC poisoning 
 To know the prevalence of pancreatitis in OPC poisoning 
 To find the association of hyperglycemia and elevated pancreatic enzyme level 
REVIEW OF LITERATURE: 
             OPC is most popular and widely used insecticide in india. It is consumed as either  
suicidal or unintentional as in case of  occupational exposure.These compounds are available  
as dusts, granules, or liquids.Toxicity profile varies for different compounds. Also the  
toxokinetics varies depends on the route of administration  such as transdermal ,  
trans conjunctival, inhalational through mucosa of  respiratory tract, gastrointestinal tract. 
                       It  was used as bio weapon in 1995 tokyo subway attack. Nerve agents used  
was sarin.Because of its increased use and its popularity incidence of poisoning is also 
 high.Severity of poisoning depends on various factors such as type of compound, amount,  
route of exposure and time taken to treat the patient. 
                     Increased incidence is noted in men because of work- Related exposure and 
 increased suicidal attempts.Common cause of mortality is respiratory failure followed by  
cardiac events.Also contributed by unnoticed complication so called acute pancreatitis 
As evidenced by studies conducted in Yuuncu Yol University  which  includes 159 patients  
 of which 36% percent showed hyperamylasemia.Among them one-third have elevated lipase 
levels. 
             Dressel and colleagues  have one experiment in dogs about  anti-cholinesterase  
induced pancreatitis secondary to  stasis of  exocrine secretions. From a case report from 
 University of Manitoba it is shown that 7% of patients shows hyperglycemia  .14% percent 
shows  glycosuria, paradoxically hypoglycemia is also reported. 
This effect is either due to insulin secretion by cholinergic stimulation or whether the  
hyperglycemia in OPC  is  due to secondary hormonal effects to hypoglycaemia  or due to  
 necrosis of pancreas, is still  unclear. 
ABOUT PANCREAS: 
ANATOMY OF PANCREAS: 
 Pancreatitis is the pathology characterised by inflammation of pancreas.As the common bile 
 duct and pancreatic duct have common pathology, either pancreatic enzymes or bile can  
 reflux into the above ducts and cause theorgan damage. Gall stone is the common implicated  
culprit followed by Alcohol, toxins and drugs. 
It can lead to various secondary pathological changes due to near by  association of superior 
 mesenteric artery, vein, and bowel structures.It causes aneurysm of superior mesenteric  
artery, thrombosis of superior Mesenteric vein and  ischemia of surrounding bowel loops. 
So it can lead to rupture of artery and torrential bleed and hemodynamic compromise. 
 
 As pancreas is a retro-peritoneal  organ , bleeding from it can track either  anterior to 
thoracolumbar fascia and perirenal fascia and appears as  Cullens sign  around the umbilicus.  
On the other way it can track through lesser omentum , to appear as Grey-Turners  sign near 
flanks.. 
       Due to close relation to stomach  any inflammation in and around pancreas can cause  
stasis and vomiting due to involvement of superior mesenteric plexus, which contributes  
autonomic supply , that explains  paralytic ileus in pancreatic  inflammation.In severe to 
 chronic cases , fluid accumulates around the  pancreas that leads to collection of fluid called  
as pseudocyst. 
  
FUNCTIONS OF PANCREAS:It weighs about 70gm in adult male and 66gm in adult 
female It has both endocrine and  exocrine function.It helps in digestion of fat. Islets of 
Langerhans are the functional unit of Pancreas. They secrete  four polypeptide hormones like 
insulin, glucagon, somatostatin,and pancreatic polypeptide.They help in the metabolism of  
carbohydrates, proteins and fat.Per day healthy adult secretes around 35-100 units… 
REGULATION OF PANCREATIC SECRETION: 
The exocrine pancreas is influenced by both hormonal and neural systems. Secretin is 
 secreted from duodenum evoked by gastric acidity. 
 It controls the bicarbonate rich secretion from the pancreas. CCK controls the enzyme rich 
 secretion which is evoked by the long chain fatty acids , essential amino acids.The  
parasympathetic nervous system  have afferent   and efferent through  Vagus that controls 
 mainly the enzyme  rich secretion .Hormonal effects mainly control the bicarbonate rich  
secretion.  
        Vagal stimulation  causes release of vasoactive intestinal peptide (VIP),secretin agonist. 
Pancreatic exocrine secretion is mediated by inhibitory neuropeptides such as somatostatin,  
pancreatic polypeptide, peptide YY, neuropeptide Y, enkephalin, pancreastatin, calcitonin  
gene–related peptides, glucagon, and galanin.  
Water and Electrolyte Secretion: 
Bicarbonate is the anion which is a physiological buffer. The ductal cells concerned with 
 secretion of bicarbonate which is predominantly (93%) derived from plasma. Bicarbonate 
 gain entry through sodium bicarbonate- chloride  exchanger  which is mediated by CFTR  
channel(cystic fibrosis transmembrane regulator)  through which chloride efflux occurs 
 during depolarisation.Bicarbonate secretion is augmented  by secretin.It neutralize the acid 
 PH and create environment for  absorption of  bile salt and fatty acids. 
 
 Enzyme Secretion 
The acinar cell secrete enzyme rich fluid and highly compartmentalised. The pancreas 
 secretes amylolytic, lipolytic, and proteolytic enzymes. Amylase an amylolytic enzyme, 
 breaksdown starch to oligosaccharides and to the disaccharide maltose.Lipase,phospholipase 
 A2, and cholesterol esterase comes under lipolytic  enzymes.  Bile salt stimulates  
phospholipaseA2 , cholesterol esterase, but inhibit  the lipase which is hampered by co- 
lipase. Proteolytic enzymes are secreted in  inactive form as zymogen  includes both 
 exopeptidase and endopeptidase .Exopeptidase includes aminopeptidase and  
carboxypeptidase that cleaves N- terminal amino group and C-terminal  carboxyl group 
 respectively. Endopeptidase cleaves the internal bond formed between nucleic acid 
 Enterokinase, duodenal mucosal enzyme  that breaks  the lysine- isoleucine bond of  
trypsinogen to form trypsin. Trypsin stimulate other proteolytic enzymes. To summarise,all  
pancreatic enzymes are activated in  alkaline PH.  Neural control plays major role in 
 mediating the enzyme rich secretion.  
Autoprotection of the Pancreas 
Autodigestion of the pancreas is hampered  by the compartmentalised pancreatic proteases in 
 inactive form and by the synthesis of protease inhibitor.These protease inhibitors are found 
 in the acinar cells, the pancreatic secretions, and globulin1 and2 fractions of plasma.  
Tests useful in diagnosis of pancreatic  disorders: 
More than 90% of the pancreas must be damaged  before the symptoms of  exocrine 
insufficiency manifests. 
Noninvasive tests of pancreatic exocrine function such as fecal elastase are  abnormal in 
 patients with obvious pancreatic disease than in patients with occult disease. 
Test pertaining to pancreatic enzymes: 
Serum amylase  and  Serum lipase. 
Amylase can be tested in serosal  cavity collections such as pleural fluid  and  ascitic fluid. 
It is not specific as non- pancreatic disorders  can also  show hyperamylasemia and so many  
false positive results can occur. 
Tests pertaining to pancreatic structure: 
Includes both invasive and non-invasive radiographic techniques. 
Plain film of abdomen shows calcification if any. 
Ultrasonogram – can show any fluid collection , mass, pseudocyst. 
CT – abdomen-  clear anatomical description of pancreas including the ductal system.  
ERCP( endoscopic retro-grade cholangio pancreatogram) 
MRCP( magnetic resonance cholangio pancreatogram) 
Endoscopic ultrasonogram  ,CT- guided pancreatic biopsy 
Tests for exocrine function: 
Analysis of duodenal contents: 
Secretin-pancreozymin-CCK test,  Endoscopic secretin –CCK test 
Examination of intraluminal products of digestion: 
Microscopic examination of stools for digestive products of fat 
Quantitative analysis of fat  ,Fecal nitrogen and elastase 
Pancreatic enzymes in body fluids: 
The serum amylase and lipase levels are used as screening tests for suspected  
acute pancreatitis.  Three fold rise of enzymes clinch the diagnosis excluding  bowel 
perforation . Within 24 hours of onset of pancreatitis  the enzymes will elevate  and  
remains for 3–7 days. Levels usually return to normal within 7 days unless there  
is pancreatic ductal obstruction, or pseudocyst formation. The values may be normal if there 
 is delay in collection of sample, or chronic pancreatitis or elevated triglyceride levels. 
The serum amylase can be elevated in other non- pancreatic  conditions like diseases of  
salivary glands, fallopian tubes, lung, thyroid, and tonsils and various other tumors.  
 Causes of hyperamylasemia: 
Pancreatic disorder:  Acute and chronic Pancreatitis. Complications of  
pancreatitis  such as  Pancreatic pseudocyst, pancreatic ascites , pancreatic abscess, 
pancreatic necrosis, pancreatic trauma and Pancreatic carcinoma.. 
Non-pancreatic disorders: 
 Renal insufficiency , Salivary gland lesions such as parotitis caused by Mumps  and  
Calculus."Tumor" hyperamylasemia - Carcinoma of the lung , Carcinoma of the esophagus ,  
breast carcinoma, ovarian carcinoma , burns, Diabetic ketoacidosis, Renal transplantation , 
 Cerebral trauma and drugs such as  morphine. 
Other Abdominal Disorders 
Biliary tract disease like cholecystitis, choledocholithiasis. Intraabdominal disease like  
perforated or penetrating peptic ulcer. Intestinal obstruction or infarction, Ruptured ectopic 
 pregnancy Peritonitis, Aortic aneurysm, Chronic liver disease, Postoperative 
 hyperamylasemia. 
Acute Pancreatitis: 
Pancreatic inflammatory disease may be classified as (1) acute pancreatitis or  
(2) chronic pancreatitis. The pathologic spectrum of acute pancreatitis varies from interstitial 
 pancreatitis, milder form, to necrotizing pancreatitis , severe form. 
Common Causes   
Gallstones (including microlithiasis) ,Alcohol (acute and chronic alcoholism)  
Hypertriglyceridemia ,Endoscopic retrograde cholangiopancreatography (ERCP) 
Trauma (especially blunt abdominal trauma)  Postoperative (abdominal and non abdominal  
operations), Drugs (azathioprine, 6-mercaptopurine, sulfonamides, estrogens, tetracycline, 
 valproic acid, protease-inhibitors), Sphincter of Oddi dysfunction.  
Uncommon Causes   
Vascular causes and vasculitis (ischemic-hypoperfusion states after cardiac surgery)  
 Connective tissue disorders and thrombotic thrombocytopenic  purpura (TTP) ,Cancer of the  
pancreas,  hypercalcemia ,Periampullary diverticulum , Pancreas divisum ,Hereditary 
 pancreatitis  Cystic fibrosis  and Renal failure . 
Rare Causes   
Infections (mumps, coxsackievirus, cytomegalovirus, echovirus, parasites)  
Autoimmune (e.g., Sjögren's syndrome) 
Clinical features: 
Abdominal pain is the major symptom of acute pancreatitis.Pain  characterised by   steady  
and boring in character, is located in the epigastrium and periumbilical region and often 
 radiates to the back.The pain is frequently more intense when the patient is supine, 
sometimes relieved by  sitting and bending forward .low-grade fever, tachycardia,  
hypotension ,and  shock. Jaundice occurs infrequently; when present, it is usually due to 
 edema of the head of the pancreas with compression of the  intrapancreatic portion of the 
  common bile duct. Erythematous skin nodules due to subcutaneous fat necrosis. Pulmonary 
 findings, includes basal crackles, atelectasis, and  left sided pleural  effusion commonly. 
Grey turner and cullens sign are uncommon, indicate the presence of a severe  necrotizing 
pancreatitis. 
  
  
Laboratory evidence: 
Leucocytosis, azotemia, hyperglycemia, hypertriglyceridemia, hypocalcemia, 
 raised haematocrit, hyperbilirubinemia ,hypoxemia, ST-T changes in  ECG. 
 
 
  
STRUCTURE OF OPC: 
            Most commercially used OPC contain pentavalent phosphorus linked to oxygen by a 
double bond , two variable groups R1 and R2. X is an ester linked arrangement which is also 
called leaving group , that is easily hydrolysed when OPC combines with the enzyme. 
 
Instead of oxygen atom if there is sulphur atom  it is  organophosphorothiates. It has to be  
converted to oxon derivatives by microsomal enzyme p450 so that they inactivate the  
enzyme  more potentially. 
  
 
TOXICOKINETICS: 
            Absorption:  It is proportional to contact time with skin. Also it depends on lipid  
solubility and nature of solvent, permeability of clothing, volatility, finest nature, if it is in  
powder form. Also absorption depends on area of skin for example more absorption takes 
 place in scrotal skin, axilla, skin of head and neck  than skin of hands, also traumatised skin 
  dermatitis favours the absorption. 
Distribution & storage: 
                         Generally  OPC  are  lipophilic, and cross the blood brain barrier. The 
 phosphorothioates (P=S), for example diazonin, parathion, and bromophos, are more  
lipophilic than phosphates (P=O).So they are stored in fat, liver, kidney, and salivary glands. 
 This may be reason for prolonged toxicity and relapse after recovery. 
Bio-transformation: 
                      OPC such as phosphorothiotes  have to be activated to oxons  by 
monooxygenase system  mediated by  P-450 isoforms. It is a  combination of  oxidation and 
 desulfuration  reaction. Whereas phosphates are biologically active  and its action is 
 immediate but, thioates actions are delayed.These oxons  are deactivated by hydrolases. 
 Elimination:  
            Mainly through urine  also through faeces.Compounds such as diazinon  are  
eliminated within hours whereas others will take days as they are  stored in fat. 
OPC & respiration: 
      Respiratory neurons are located in medulla and pons  as  three groups.The dorsal 
 respiratory group in the medulla is located in the nucleus tractus Solitarius. The ventral 
 respiratory group is located in the ventrolateral medulla and is divided into three regions, 
 caudal, intermediate and rostral. The rostral ventral  respiratory group contains the pre- 
Botzinger complex. The pontine  respiratory group (also called the pneumotaxic center) is 
 located in the nucleus  parabrachialis medialis and the Koliker-Fuse nucleus.  
HERING-BREUR reflex mediated by activation of stretch receptors that lead to  temporary 
  cessation of respiration. Cough reflex is also initiated through same mechanism , that is 
 mediated  through  C- fibres. Fluid in alveoli will stimulate the   J- receptors that cause 
 reflex tachypnoea. 
 
Pulmonary activities are mediated by post-junctional effects of acetylcholine.  Acetylcholine 
 is accumulated in synaptic vesicles at the post-synaptic nerve terminals and depolarization 
 of the nerve terminal causes release of acetylcholine into the synaptic cleft, where it diffuses 
 to interact with both pre- and post-synaptic receptors.. Two cholinergic mechanisms 
 modulate pulmonary vascular tone, a direct  stimulatory effect and an indirect  endothelium 
 dependent(nitric oxide) relaxing effect. Acetylcholine also inducesbronchial smooth muscle 
 constriction, regulating bronchial airflow narrowing the airway diameter. Airway smooth 
 muscle contraction is induced by muscarinic receptors (M2 and M3).Bronchospasm is a  
common complication of acute OP poisoning. Stimulation of sympathetic fibers   causes  
relaxation of bronchial  smooth muscle while stimulation of parasympathetic fibers causes  
bronchoconstriction.  Efferent signals carried by vagus mediated  by substance P and 
 acetylcholine results in bronchospasm.Effects from a variety of local  compounds mediate 
 changes in bronchial tone  with compounds such as acetylcholine, histamine, serotonin, 
 leukotrienes, adrenergic agonists and others mediating bronchoconstriction and compounds 
 such as ß2-agonists, nitric oxide, and others mediating bronchodilatation.OP causes  
alteration in diffusion capacity through various mechanisms. One among them is altering the  
calibre of pulmonary vasculature.  
Pooling of pulmonary  secretion in OPC poisoning is mediated by both local causes and  
neurogenic causes. Respiratory failure in OPC poisoning occurs  through two mechanisms:  
central apnea and pulmonary dysfunction mediated by vagus nerve. 
As per one study, after vagotomy the central mechanism for respiratory control  
ceases and that leads to  hypoventilation  further leads to apnoea. As per another study 
 conducted in animals ,vagal denervation interrupts the efferent signals from bulbar nucleus  
to lungs that leads to defect in alveolar level.The effects of OP in cardio-vascular system 
 includes variation in blood pressure,  pulse rate, various types of arrhythmias and it does not 
 correlate withpulmonary diffusion capacity and  central apnoea. 
OP has both central effects and direct effects in heart.  Stimulation of vagus  cause 
 constriction of bronchial smooth muscles and dilatation of pulmonary vasculature that leads 
 to  ventilation-perfusion (V-Q) mismatch. These changes collectively increase the arterial – 
 alveolar gradient in OPC poison. 
MECHANISM OF ACTION & PATHOPHYSIOLOGY: 
      OPC acts by binding to active site of acetylcholine esterase by stereotypic inhibition .The 
 signs and symptoms  is due to acetylcholine excess in neuromuscular junction.It has both 
  muscarinic and nicotinic actions.It acts on post ganglionic parasympathetic secretory  
glands, smooth muscles of respiratory tract, gastro-intestinal tract, bladder, eye, and heart. 
 Also it acts on post ganglionic sympathetic sweat glands leading to constellation of signs  
and symptoms such as increased secretion in lungs, and so on. 
It acts on nicotinic receptors leads to persistent depolarisation. Also it crosses the  
blood-brain barrier leads to CNS depression for  reasons unknown. OPC also binds to RBC 
 cholinesterase and plasma cholinesterase, but the clinical effects  were not explained. Its  
action is irreversible which is explained by process called  ageing in which the 
 phosphorylated enzyme loses the alkyl side chain non-enzymatically.The rate of hydrolysis 
 of OPC- enzyme complex is more  when compared to acetyl choline- enzyme complex as  
the former conjugate is relatively stable and resistant to hydrolysis, so it takes weeks to days 
 for the enzymes to recover.  
 
         
 Apart from acute complications , there are certain delayed neurological manifestations  
which is explained by non- cholinergic Target sites such as NTE(neuropathy target esterase). 
 It also causes disorganisation of membrane, cyto-skeleton, interrupts the protein 
phosphorylation, cell turn over, and affects various signalling pathways,so that it affects the 
 neuronal proliferation,survival. 
It also interacts with non-esterase protein called tubulin.It also causes mitochondrial 
 dysfunction, lipid peroxidation,Protein misfolding, affect ubiquitin- dependent pathway 
 ATP- depletion,, so that it affects the ATP dependent process such as axon transport 
essential for nerve regeneration. 
Binding to NTE may affect both its channel role in the endoplasmic reticulum and its lipid  
hydrolase activity, causing disruption of membranes with potential Ca2+ release, membrane  
cleavage and  cell death. 
MOLECULAR TARGETS OF OPC: 
Neuropathy target esterase (NTE): 
NTE is a membrane protein located in smooth endoplasmic reticulum able to conduct ions is 
 stored in vesicles.. OPCs  that are able to induce aging of NTE capable of blocking ion- 
 conductance thus leading to OPIDN. Also it has lipid  hydrolase  activity, phosphotidyl  
choline as a substrate. It plays a role in the regulation  of phospholipid turnover in cell  
 membranes.NTE sequence is similar to swiss cheese protein (SWS)in drosophila 
 Melanogaster,, so mutation of SWS sequence can lead to neuropathy.This degenerative 
 condition associated with  wrapping of glial cells, apoptosis  of neurons, dysregulation of  
 phospholipids. As per  Glynn  Proposal  inhibition  and aging of NTE  will affect the NTE 
  related  function such as  lipid hydrolysis or ion-channel activity.NTE mutants with 
 diminished esterase activity leads to motor neuron disease. 
 Role of NTE in neuronal differentiation: 
 Exposure  of differentiating neuroblastoma cells to OPIDN inducing OP , like PSP(phenyl 
 saligenin phosphate)  will reduce the growth of axon like process. Some studies shows that 
 knocking of NTE in differentiating SH-SY5Y cells does not affect the neurite growth. This 
 suggest that there is some other factor other than NTE  is involved in neurite growth.By one 
 study the increased expression of NTE will cause mitotic arrest in renal cell line. 
Other targets: 
Cyto-skeletal proteins: 
TOCP exposure will cause  hyperphosphorylation of cyto-skeletal proteins.Histo-pathology 
 shows aggregation of neuro-filament heavy chain  before the development of OPIDN. As 
 per one study  however, PSP exposure in differentiating N2a cells is found to cause 
 increased  activity of the mitogen activated protein MAP kinase for which NFH is a 
 substrate this agent was able to affect cytoskeletal integrity by disruption of signalling 
 pathways associated with neuronal cell differentiation and survival. Neurite inhibition was 
 associated with increased levels and phosphorylation of  the actin binding protein  
cofilin.Cofilin regulates the dynamic properties of the microfilament network.   
Proteolytic enzymes: 
        Wallerian degeneration is due to calcium influx , activation of calcium dependant 
 calpain. Calpain‑mediated proteolysis of cytoskeletal proteins such as neurofilaments  
is an early event in OPIDN.This is evident by using calcium channel blockers in treating 
 symptoms of  OPIDN. Another inducer of OPIDN other than calpain for 
example,diisopropylphosphorofluoridate (DFP) is also involved in axonal 
 degeneration.Apart from this major pathway affected is ubiquitin- dependant  pathway 
  which is involved in protein folding.so disruption  of  this pathway  leads to protein 
  misfolding &aggregation.. 
Mitochondria: 
           Impairment in the activity of a range of key mitochondrial enzymes such as succinate 
 dehydrogenase, NADH dehydrogenase and cytochrome oxidase. Such that it disrupt the 
  energy metabolism, respiratory chain, disruption of transmembrane potential, leads to 
 depletion ATPs  thus leads to apoptosis. 
OTHER POTENTIAL ‗NON‑ESTERASE‘ OPC BINDING PROTEINS 
  Other than AChE, NTE and other serine hydrolases alternative OP binding  sites are 
 tyrosine and lysine residues. OPC binding to albumin  was detected by  mass spectrometry  
and of prognostic significance.Chlorpyrifosoxon disrupts microtubules  by preventing 
 polymerisation. Further analysis by mass spectrometry demonstrated the covalent 
 interaction  of chlorpyrifos with tyrosine residues in tubulin.This explains the  
developmental defect after exposure to OPC. 
 The degree of organophosphate intoxication: 
Grade 0: No clinical signs or symptoms 
Grade 1:   increased secretion, twitching, normal level of consciousness  
Grade 2: Grade 1 + hypotension, loss of consciousness 
Grade 3: Grade 2 + not responding to noxious stimuli , chest X-ray showing  
features suggestive of ARDS , pO2< 10 mmHg. 
ACUTE TOXICITY OF OPC: 
      Diarrhea/ abdomen pain--- muscarinic stimulation of colonic non-striated  muscle and 
  decreased water absorption .Micturation—muscarinic stimulation of detrusor.Miosis--- 
 cholinergic stimulation of sphincter pupillae causing constriction of pupil .Bradycardia ---- 
vagal  stimulation of muscarinic receptors or reflex bradycardia from increased sympathetic  
nerve activity.Tachycardia---- cholinergic stimulation of receptors in the sympathetic 
ganglia and adrenal medulla with release of catecholamines.. 
 
 
  
 
 
 
 
 
Bronchorrhoea/Pulmonary Secretions---cholinergic stimulation of pulmonary goblet cells 
 and glands  or reflex bronchorrhea from pulmonary afferent activity via the nucleus of the 
 solitary tract.Bronchoconstriction--- cholinergic stimulation of bronchial smooth muscle or 
 reflex bronchoconstriction from pulmonary afferent activity via the nucleus of the solitary 
 tract.Emesis--- cholinergic stimulation of stomach smooth muscle and gastric secretion via 
 muscarinic receptors as well as brainstem triggered ―motion sickness‖ with nausea and 
 vomiting.Lacrimation--- cholinergic stimulation of lacrimal glands.Salivation ----cholinergic 
 stimulation of salivary smooth muscle and exocytotic secretion. Fasciculations ----nicotinic   
stimulation of skeletal muscle fibers. 
 Summary : 
Muscarinic receptors: 
Decreased heart rate,bronchospasm, bronchorrhoea,decreased blood pressure, diarrhoea, 
 abdominal cramps, constricted pupils and increased salivation. 
Nicotinic receptors: 
            Increased heart rate, increased blood pressure in 20% ,fasciculation, striated muscle 
necrosis. 
Both central muscarinic and nicotinic receptors: 
               Tremor, loss of coordination, seizures, respiratory depression, coma, and death. 
 
INTERMEDIATE SYNDROME: 
              Occurs during one to four days after exposure,characterised  by respiratory 
 paralysis, weakness of flexors of neck, proximal limb muscles, cranial nerve palsy, 
 opthalmoparesis. Due to inadequate  treatment or delayed  treatment.. 
OP‑Induced Delayed Neuropathies (OPIDN): 
          OPIDN is a neurodegenerative condition that affects long  tract  in both central and  
peripheral nervous system,characterised by delayed onset of symptoms from exposure to  
OPC. Symptoms starts by sensory disturbances in the form of numbness, paraesthesia in  
lower limbs associated with cramps followed by ascending type of flaccid motor weakness,  
with hyporeflexia with or without  bladder and bowel disturbances ,loss of balance,  
steppage- gait. Brisk reflexes with  spasticity supervenes during  recovery, in the form of  
hyper reflexia, spastic gait and increased motor tone. 
Lipid soluble OPC such as fenthion may produce extra-pyramidal symptoms like  
dystonia, cog- wheeling, tremors.Peripheral delayed  sensory- motor  neuropathy occurs due  
to dying- back process of axonal degeneration. 
Cognitive dysfunction in the form of deficits in concentration,  memory defect. Behavioural 
 disturbances in the form of  anxiety, apathy, confusion, restlessness, labile emotion,lethargy,  
anorexia, insomnia, depression,irritability. 
           Metabolic complications such as hyperglycemia, glycosuria, presenting as   
hyperglycemic keto-acidosis, non-ketotic hyper glycemic acidosis.Parathion known to cause 
 hemorrhagic pancreatitis which is fatal. Diazinon is also implicated in this scenario. Above  
all OPC is teratogenic as evidence by an incident in Hungarian  village .Pregnant lady 
 consumed fish contaminated by trichlorphos, 11 out of 15 live birth has congenital  
anomalies.Some reported anomalies are downs syndrome, ventricular septal defect, 
 pulmonary atresia, anal atresia, stenosis of left bronchus.. 
       In children it is also associated with certain non- hodgkins  lymphoma such as burkitts 
 lymphoma, lymphoblastic, large- cell, T-cell and B- cell lymphomas .Pediatric patients had 
 predominately CNS depression and severe hypotonia, whereas muscarinic symptoms were 
 infrequent. 
DIAGNOSIS: 
 Depression of cholinesterase activity: 
     RBC cholinesterase is reliable than serum cholinesterase levels.Disadvantages includes 
 wide variable normal level in various population.False low values are seen in pernicious 
 anemia, hemoglobinopathy,anti-malarial treatment, sample collected in oxalate tube.High 
 values are seen in reticulocytosis seen in anemia, haemorrhage, or else treated for anemia. 
Depression of plasma cholinesterase activity: 
       Less than 50% reduction is less reliable indicator . More than 90% Reduction indicates 
 increased mortality.As it is a liver protein, it is decreased in cirrhosis, malnutrition, chronic  
debilitating conditions, drugs  such as  succinyl choline, lignocaine, morphine, chloroquine.. 
p-nitrophenol test:   metabolite of some OPC such as parathion excreted in urine.  
This test also done in vomitus or gastric contents.Some studies shows that urine alkyl 
phosphates are more sensitive markers. 
Thin layer chromatography(TLC): 
 Presence of OPC in vomitus,or gastric aspirate sample is determined  by TLC . 
Other ancillary investigations  shows leucocytosis, high haematocrit, hyperglycemia, non- 
anion gap acidosis.ECG may show QTc prolongation or VPC, chest x ray shows evidence of  
aspiration  pneumonitis , serum electrolytes, pancreatic amylase, CT-abdomen have to be 
 taken if pancreatitis is suspected. 
LEUCOCYTOSIS: 
                 Increase in number of white blood cell due to acute inflammatory reaction. 
It may be  due to increased production from bone marrow , or increased release from 
  marrow, or decreased  margination or extravasation into tissues.Causes include any  
chronic infection/ inflammation will cause growth factor dependent leucocytosis.  
Growth factor independent  process is seen in myeloproliferative   disorders.There are 
 various types of leucocytosis such as neutrophilic , eosinophilic, basophilic, monocytic , 
 lymphocytic leucocytosis.Morphology of  neutrophils are classic  as seen in sepsis, example 
 toxic granulations., dohle bodies. 
TREATMENT: 
         First and foremost step is identification of chemical and the attender is asked to bring 
 the container or label  as different OPC have different ageing and reactivation times. For 
 example dimethyl OPC have  early ageing so oximes should be initiated early. Diethyl OPC 
 have delayed ageing so oximes have to be prolonged. 
GOALS OF TREATMENT: 
Airway, breathing, and circulation (ABCs): should be initiated first .Reduce absorption of  
the toxin (xenobiotic). Enhance elimination and neutralize toxin.Reduce absorption by 
 decontamination of skin, eyes and hair, emetics, stomach wash, activated charcoal ,whole 
 bowel irrigation. Skin decontamination– remove contaminated clothing and wash with soap 
 and water. 
Gastric Lavage: 
              Gastric lavage reduces absorption by 40% if done at 20 minutes and by 14% 
 if performed at 60 minutes. Performed by repeated aspiration after instillation.  Left  
lateral position delays absorption. Simplest, quickest and least expensive way is by means 
 of funnel. Choice of fluid is tap water: 5–10 mL/kg.Preferably done on awake 
patients.Presence of an ET tube does not preclude aspiration. No human studies  
in OPC shows benefits of gastric lavage. 
Atropine: Atropine is a pure  muscarinic  antagonist that competes with ACh at the 
  muscarinic receptor. 
 Atropinization Targets: Mandatory targets: 
 SBP greater than 100 mm Hg, Heart rate more than 110/minute, lung fields clear. 
 Other targets:  Pupils dilated and  Bowel sounds sluggish. 
Targets on subsequent days:  Day 2: HR greater than 100/minute 
 Day 3: HR greater than 90/minute ,Subsequent days: At least 80/minute. 
Several recommendations > 20 mg atropine  0.02–0.08 mg/kg over 1 hour  would take 4  
hours to give 20 mg atropine to a 70 kg male. a minimum dose  to prevent reflex 
 bradycardia. Atropine may be redosed every 5 to 10 minutes.Disadvantage: not acting on 
 nicotinic  receptors. So not effective against  neuro-muscular manifestations. 
 
OXIMES:              
 They are nucleophilic compounds compete with active site of bound acetylcholinesterase 
  and reactivate them. The reactivation time varies depending  upon ageing of various 
  compounds.so it have to be initiated as early in  dimethyl containing compounds and has to 
 been given for prolonged period in diethyl compound. Only available compound in united 
 states is pralidoxime since 1950 .Now newer drugs such as obidoxime and trimedoxime  
are  available.As per largest Oxime Trial treatment recommended is 2 g loading dose over 20 
 minutes,then 0.5 g/hour for maximum 7 days.Current evidence is insufficient   and further  
studies have to be done  to indicate whether oximes are harmful or beneficial.  The WHO 
 regimen (30 mg/kg  pralidoxime chloride bolus  followed by 8 mg/kg/hour infusion) is not   
in use in many centres reason for failure of oxime therapy  is too early or delayed 
 presentation, dosage used, type of OPC, toxicity of antidotes. 
One study by Johnson et al was a comparison  of bolus (1g)dosing versus Pralidoxime(12g) 
 infusion.  Mortality was higher in second group. 
 Another study by Cherian et al was a comparison of pralidoxime 12 g given over 3 days 
 versus placebo..Mortality was higher in both groups. 
A recent study by Pawar et al compared continuous infusion of  Pralidoxime, 1g/hour versus 
  1g fourth hourly. Both groups received 2g bolus  dose.This reduces the need for intubation 
 and  minimize the dose of atropine. Former Group does better compared to later.  
 In OP poisoning it is hypothesized that  butyrylcholinesterase  present in FFP will sequester 
 free unbound OPC present in blood and remove  them from circulation .Based on various 
 studies about bioscavenger therapy that fresh frozen plasma  appears more harmful and  
prolongs the period of  ventilatory support and intermediate syndrome. Also albumin as a 
 bioscavenger therapy is also tried and of no proven benefit. This harmful effect  is due 
 release of sequestered OPC into circulation. 
 
 
 
 Early Enteral Feeding :   
                                      Early institution of enteral feeds may improve the  outcome as it 
  prevents  entero-hepatic circulation.  Early nutritional supplementation in OP poisoning 
 may be harmful as it can  lead to development of respiratory failure due to intermediate 
 syndrome. 
 Clonidine is a centrally acting sympatholytic used as antihypertensive drug.  It inhibits 
 presynaptic release of acetylcholine, thereby decreasing the cholinergic symptoms.  There  
is no benefit in OPC poisoning compared to side effects  such as hypotension, bradycardia, 
 rebound hypertension, sedation. 
Charcoal: Activated charcoal has been widely used for absorbing poisons including  
pesticides, plant poisons, and drugs. The two methods of charcoal administration are   
single dose activated charcoal ,multiple dose activated charcoal. Charcoal adsorbs 
 organophosphates and therefore may have a potential benefits  in the treatment.  
Gastric Lavage:  Gastric lavage is most commonly used decontamination procedure  across 
 Asian  countries.Organophosphates are absorbed  easily through mucous membranes and  
gastric lavage may play a role in the early poisoning. 
 Alkalinisation by sodium bicarbonate have some benefits as the  alkalinised  products of 
 some nerve agents  soman are least toxic . MgSO4  4g iv  improve outcomes in patients with 
 OP poisoning. Magnesium sulphate blocks calcium channels and  thus reduces acetylcholine 
 release. It  reduces CNS overactivity due to N-methyl D-aspartate receptor activation. 
 Forced emesis (Ipecac) should not be performed  because they may delay specific life- 
saving treatment.Adverse effects of ipecac may include bloody vomitus,loose stools, 
 paralytic ileus, aspiration. 
Role of benzodiazepines: 
 Used in OPC  for control of agitation, sedation in ventilated  patients, and for control of 
 seizure . Diazepam, midazolam, lorazepam are commonly used drugs.They act by  
depressing all levels of activity, by increasing GABA activity,dose of lorazepam  should not  
exceed 2mg/min,used for treating the status.Midazolam is water soluble takes longer time to 
 act .It is also used for status especially when refractory. 
 Cathartics will reduce the transit time so that increase the passage of poison in GIT, so 
 absorption will be reduced. 
 Gacyclidine is an anti-glutaminergic compound  used in conjunction with  anti-oxidants 
 have some beneficial role in OPC as there is induction of reactive oxygen species and lipid 
 peroxidation,increased thiobarbituric activity. Role of hemodialysis, hemofiltration, 
 hemoperfusion in OPC is unclear. 
COMPLICATIONS: 
                  Most common mode of exposure is ingestion followed  by  dermal exposure and 
 Inhalation. 
Acute complication include, that is within 4 weeks seizure,hypotension,hyperglycemia, renal  
failure and diarrhoea. 
Delayed complication include neurological deficit such as monoplegia  involving lower limb 
or  paraplegia with mild sensory involvement. 
Mortality is mainly due to ARDS, arrhythmia and renal failure. 
Iatrogenic complication is more common , example atropine  overdose cause delirium, 
 hyperthermia, diminished bowel activity, urinary retention, dryness of mouth as the famous 
 saying, hot as hare, red as beet, dry as bone, etc.  Treatment  simply  stop  atropine until 
 cholinergic symptoms supervenes. 
  Acidosis  includes both metabolic, respiratory sometimes mixed  component.Among them 
 most common is metabolic component. Acidosis is due to tissue hypoxia, and treatment 
 includes adequate  oxygenation, ventilation and replacement of fluids.Mortality is mainly 
 due to  cardio vascular causes such as arrhythmias , followed by respiratory failure.So early 
 arterial blood gas analysis and interpretation of complications is of  prime significance. 
 Respiratory infection due to aspiration, ventilator associated pneumonia 
and its treatment with antibiotics is off little use. 
Apart from muscaranic, nicotinic, central CNS symptoms  patient sometimes  
develop  extrapyramidal features such as tremors, rigidity, bradykinesia to akinesia. 
This is explained by a hypothesis, that the striatoniagral  cholinergic neurons had diminished 
  anticholinesterase activity, thus reducing cortical glutamate activity.It is supported  by  fact 
 that treatment by  amantadine reverses the symptoms  probably due to anti-glutaminergic 
  activity and due to NMDA antagonism. Other explanations such as hypoxic encephalopathy 
  or dopaminergic  changes  have no evidence. Though the parkinsons features are  
transient  it has to be diagnosed promptly to reduce complications. 
       Leucocytosis is a common finding. It suggest the prognosis such that  normal count on 
 admission have less complications. It has to be serially monitored. Increased count despite 
 treatment succumbs to complication such as  respiratory failure, chest infection, urinary tract 
 infection. 
BIOCHEMICAL CHANGES: 
 Respiratory changes:  Loss of respiratory drive  leads to bradypnoea or apnoea.Some  
studies shows that there is no evidence of respiratory muscle paralysis, as diaphragm is 
 intact. 
Hepatological  changes: both activation and de-toxification   occurs in liver. 
 Some  histological changes  occurs are congestion, centri-lobular necrosis, fatty  
changes  and sinusoidal dilatation. 
Cardiovascular changes:  Myocardial  necrosis as evidenced by increase in creatinine 
 phosphokinase and lactate dehydrogenase. Other changes include sinus  tachycardia, 
 sinus bradycardia, hypotension, hypertension. ECG changes  include ST elevation, QTc 
 prolongation, low amplitude T wave,ventricular premature complexes , various degrees of 
 heart block as evidenced by prolonged  PR interval. 
Neurological disorders: 
 Cognitive dysfunction and defective in working memory are  usually seen as chronic 
 complication.The symptoms even persists for  more than 6months.Other syndrome include 
 parkinsonism, pseudobulbar features sometimes cerebellar features. 
Four types of neurological manifestations: 
 cholinergic crisis 
 intermediate syndrome 
 OPIDN( organophosphate induced delayed polyneuropathy) 
 COPIND(chronic organophosphate induced neuropsychiatric disorder) 
CHOLINERGIC SYNDROME: 
It is the  first phase of OPC poison.Symptoms due to action of excess  of acetyl choline on 
nicotinic or muscarinic  receptors.Most severe manifestation is respiratory  failure.Also 
called as type 1 paralysis. 
INTERMEDIATE  SYNDROME: 
First coined by   senanayakae from srilanka in 1987. Described  as type2  paralysis  by wadia 
 in 1974. Called intermediate as it occurs after  initial cholinergic phase but before late 
 polyneuropathy. Mechanism remains still unclear.Usually initial manifestation is weakness 
 of neck flexors followed  by proximal limb weakness , respiratory paralysis, sometimes 
 cranial nerve palsy. It occurs after 24 to 96 hours after ingestion.Order of recovery is  
cranial nerve followed by limb and respiratory muscles.As per Gadoth and Fisher views, its 
 due to action on nicotinic  Receptors. As per senanayake its due to downregulation of 
  acetylcholine  receptors. Deep tendon reflexes are depressed, sometimes pyramidal tract is 
 involved. Decremental response at low frequency stimulation as evidenced by nerve  
conduction studies.Compounds implicated are monocrotophos, dimethoate, methyl Parathion 
 Serum acetyl cholinesterase is grossly reduced. All these patients require ventilator support. 
 Incidence is around 29%. Time of recovery is between 3 to 12 days. 
OPIDN: 
Produced by compounds having weak anti-cholinesterase activity.Example,Triorthocresyl 
 phosphate. It occurs after 7 to 21 days following exposure.Symptoms manifest initially as 
  parasthesias and leg pain, then followed by leg weakness,manifest as footdrop. Then 
 weakness of small muscles of hand later involves the truncal muscles. Cranial nerves  and 
 autonomic  system not involved.Deep tendon reflexes are absent,ataxia can also occur, for 
 such cases prognosis is guarded.Its due to aging of neuropathy target esterase. 
COPIND: 
               These effects include drowsiness,confusion, lethargy, anxiety, emotional  
lability,depression, fatigue and irritability. This is due to hypoxic sequelae  attributed to 
 respiratory failure and cardiac arrhythmias that occurs during cholinergic phase. 
Extra-pyramidal features too occurs. 
Hormonal disorders: 
               Hormonal imbalance usually involves  sex hormones .Maternal exposure may  
  lead to  foetal death, intrauterine growth retardation ,and infertility in both sexes. 
Other effects: on oesophago-gastroscopy, edema  and  bleed is seen throughout the 
esophagus. 
As per study conducted by Ontario college there is risk of renal carcinoma .Due to chronic 
exposure to pesticides among children  can lead to renal  failure.Studies shows that it‘s 
 a state of oxidative stress , as evidenced by enhanced  lipid  peroxidation and decreased 
 level of glutathione. 
LABORATORY FEATURES as observed  by HAYES et al 
As per his observation , depleted anticholinesterase is seen in 97%,  
Polymorphonuclear leucocytosis in 46%, Proteinuria in 18%,  glycosuria- 14% 
 hyperglycemia in 7 %   and abnormal ECG in 5%.. 
FUTURE DRUGS: 
Huperzine-A:(HupA) 
 Reversible inhibitor of acetylcholinesterase. Oral  formulation is derived from extracts of 
 huperzia serrata.Used for treating memory deficits in alzheimers disease, vascular 
 dementia.Now is in trial.Minimal cholinergic side effects and higher oral 
 bio-availability  and prolonged action. 
 ZT-1  similar profile compared to HupA. Both can cross the blood brain  barrier. 
Butane - 2, 3-dionethiosemicarbazone is an oxime with antioxidant properties 
Its action is to nullify the different forms of free radicals  such as hydroxyl ,nitric oxide 
radicals and inhibit lipid peroxidation. 
 Phosphotriesterases (PTEs): 
                            The main enzymatic systems involved in the detoxification of OPC are  
phosphotriesterases, carboxylesterases, and glutathione-S-transferases.Most commonly 
 studied PTESs  are paroxonases.. 
VENTILATORY MANAGEMENT IN OPC: 
According to recent guidelines:  
Direct indices: arterial oxygen tension < 50 mmHg in room air 
Arterial CO2 tension > 50 mmHg in the absence of   metabolic alkalosis. 
Derived indices: 
PaO2/FiO2 < 250 mmHg 
PAaO2 ( pulmonary arterial-alveolar O2 gradient) > 350 mmHg 
Vd/Vt >0.6 
Clinical – respiratory rate (RR) > 35 breaths/min 
Mechanical indices: 
Tidal volume 5ml/kg 
Vital capacity 15 ml/kg 
Maximum respiratory force < 25 cm of H2O  
BENEFITS of OPC: 
Apart from various adverse effects there are certain benefits as a pesticide that  
can kill pests, rodents,  that poses serious problem in community so that they  
can reduce the incidence of various vector-borne diseases,asthma and allergic  
diseases,microbial contamination and avian flu,anthrax, prion disease,etc. 
PREVENTION of OPC: 
 Adequate ventilation when applying pesticides in home. 
 Don‘t use outdoor pesticides in indoor. 
  Follow the labelled instructions and safety warnings. 
 Use ready-made products whenever possible. 
  Protect  foodstuffs and water supplies from the vicinity of pesticide. 
 Wash before consumption. 
 Container should be discarded safely. 
 Use gloves and protective jackets while applying pesticides. 
  Before using pesticides wash your hands with soap water. 
 Pesticides and poisons should be kept away from the children. 
 Adequate education about various hazards of poisons to children 
 Pouring pesticides into river, dam , toilet drain leads to contamination of water 
resources. 
      Based on various randomised control trials certain therapies are  likely to be 
 beneficial and proven ,unknown effectiveness ,unlikely to be beneficial,  
sometimes harmful. 
Of proven benefit 
Atropine, Glycopyrrolate,benzodiazepines to control organophosphorus-induced seizures  
and removing clothes contaminated with OP poison. 
Effect not known 
Activated charcoal ,Alpha2 agonists ,cholinesterase replacement therapy  
Extracorporeal clearance ,Gastric lavage ,Magnesium sulphate,N-methyl-D- 
aspartate receptor antagonists ,Organophosphorus hydrolases ,Oximes and 
Sodium bicarbonate.  
Not beneficial---Cathartics 
ineffective or harmful   -  ipecac 
Merits and demerits of various intervention : 
ATROPINE: case series shows that atropine reversed the early muscarinic  
effects of acute OP poisoning. 
Harm:  confusion and tachycardia ,ventricular tachycardias. 
OXIMES:There are various regimen followed in different centres.Accordingly  
mortality, need for ventilation, incidence of intermediate syndrome varies.Also  
it reduces the dose of atropine needed. 
Harm:   Adverse effects of oximes include hypertension, cardiac arrhythmias, 
 headache, visual disturbances, epigastric pain. Adverse effects with  
pralidoxime  due to rapid administration or   dose >30mg/kg/bolus.Obidoxime  
 known to produce hepatitis at the dose of 8mg/kg / bolus.  
General principles in management of poisoning: 
 Prevention of contamination of the  rescuing  people 
 If the victim is unconscious or gasping  for respiration, commence Resuscitation 
followed by supportive care 
 Decontamination of the patient. 
 To remove the poison from the body by various techniques 
 Specific management of particular poisons by antidotes. 
 Treatment of complications of the poison. 
 Call for help and ambulance as soon as possible. 
Prevention of poisoning of the rescuer 
 During first aid and subsequent treatment, the container should be identified to 
minimise further exposure. 
 WHO colour code on container can also give clue. 
 Monocrotophos, Phorate and Methomyl are class I toxic pesticides 
available in local market. 
 Rescuer  need to wear personal protective equipment (PPE) including  
gloves and jackets  during  decontamination. 
 
 Decontamination 
If the poison is ingested wash  their mouth with soap. Don‘t use emetics.. 
If the poison is inhaled immediately get the person to fresh air.Avoid 
 breathing fumes. 
  
 
If the poison contacts with eye warm the eye with saline or cold water. 
If the poison contacts with skin remove contaminated clothing 
 
Flood skin with running cold water. 
Wash gently with soap and water and rinse well. 
 
Resuscitation and supportive care 
A self-inflating bag-valve-mask apparatus is the safest way to provide ventilation for the 
BLS rescuer 
Specific Management of particular poison 
ANTIDOTE: 
      An antidote is a substance which can counteract a form of poisoning. 
The term derived from greek word antididonai, given against. 
Therapeutic substance used to counteract the toxic action of specified xenobiotic. 
ROLE OF ANTIDOTES: 
  Neutralise the toxin of its effects 
•  Save the patient from death 
• Shorten the hospital stay 
• Reduce the burden on health services 
• Especially important in developing countries where adequate facilities  
         are not available in primary care. 
      Unavailability of  antidotes or delayed use  could result in catastrophic sequences. 
   ANTIDOTES SHOULD BE AVAILABLE  IN EMERGENCY: 
    Activated charcoal: 
            Activated charcoal is a fine , black odourless powder made from burning wood or 
 coconut shell followed by treatment with activating agent like steam by virtue of its large 
 surface  area  it adsorbs  many drugs and toxins.Useful for drug overdose whose half-life is 
 long. 
Atropine: 
            Used in OPC, carbamate, and nerve agent poisoning.It is a parasympatholytic agent 
  that competitively blocks action of acetylcholine at  muscarinic receptors. 
Cyanide antidote  kit(CAK):   
                                            amyl nitrite, sodium nitrite and sodium thiosulphate. Useful in  
cyanide poisoning.Hydroxycobalamin is packed  to allow field use  or  pre-hospital use. 
 methylene blue: 
               Used  in methemoglobinemia with hypoxemia, dysnoea, confusion and chest pain  
or methhemoglobin level greater than 30%. It is a thiazine dye that  increases the conversion 
 of  methhemoglobin to haemoglobin. 
Oximes:  
              Pralidoxime is the only available oxime in india.It is a antidote for OPC poison.   
Also used in nerve agent agent exposure. 
Ethanol and fomepizole:   
           Antidote for suspected methanol or ethylene glycol poisoning. 
Chelating agents: 
         Capable of forming  coordinate bonds with metals  and make it water soluble  
resulting in high renal excretion. 
Example: BAL:( british anti-lewisite) used in arsenic, mercury, gold, lead poisoning. 
CaEDTA: used in lead poisoning. 
D-penicillamine: chelates lead,mercury and copper. 
DMSA: chelates  lead, mercury arsenic. 
RECOMMENDATIONS: 
•  New legislation have been adopted by ministry of health and family welfare regarding   
stocking of antidotes. 
• Co-ordination of PHC.CHC, tertiary hospitals regarding quantity of antidote and 
where to direct the poisoned. 
• Antidote bank in each state 
• Life saving antidotes should be given to  all major chemical  industries 
• Establishing a toxicology response centre- emerging need. 
Carry home messages in OPC management: 
We recommend incremental dose administration of atropine  as the  
standard of care. The role of glycopyrrolate alone or in  combination with  
atropine is not clear.Overall null effect or potential harm with oximes was found 
on meta-analysis of trials. The largest oxime study tends to harm. Fresh frozen  
plasma appeared to be more harmful than beneficial. Early institution of enteral  
feeds may be associated with improved outcomes in the critically ill as it  
prevents enterohepatic circulation . An optimum dose of clonidine with  
clonidine bolus injection (0.15–0.30 mg) followed by an infusion at the rate of  
0.5 mg/24 hours appears to be clinically acceptable in OP poisoning.  Activated  
charcoal use in acute OP poisoning: No evidence of harm or benefit. Gastric  
lavage in OP poisoning shows no evidence of harm or benefit. However, this  
being an easily performed and cheap  intervention could be used as an adjunct  
measure.Blood alkalinization with high dose NaHCO3 in OP poisoning was 
 shown to be useful. External decontamination: washing with soap and 
  water can reduce further absorption of the poison into the system 
 Intravenous MgSO4 (4 g) given in the first day after admission  has been  
shown to decrease hospitalization period and improve outcomes in patients with  
OP poisoning. Forced emesis (Ipecac) should not be performed on patients with  
OP poisoning.Benzodiazepines are widely used in OP poisoning to control  
agitation, provide sedation in ventilated patients and control of  seizures 
 Cathartics can reduce the transit time and reduces the absorption of poison 
 Gacyclidine: Antioxidants are useful adjuvant therapies in OP. 
Prognosis 
   In severe poisoning, death usually occurs within first day if left untreated. 
  With nerve-agent poisoning, death may occur within minutes if untreated. 
   Even with adequate respiratory support and specific treatment with atropine    
   and oximes, the mortality rate is still climbing in severe poisoning. 
   A delay in treatment can  lead to late neurologic sequelae. Most patients with  
   mild poison can recover completely . 
  
 
                                    MATERIALS  AND  METHODS 
study design: 
                 This is a cross- sectional study. 
Place of  study: 
                    Study was carried out in the department of  medicine , intensive medical care 
unit Tirunelveli medical college hospital. 
Study population: 
                 All patients admitted in IMCU  with alleged history of consumption of OPC  
Poisoning. 
Inclusion criteria: 
             All patients (both males and females) admitted in the IMCU with consumption of 
organophosphorus compound. 
Exclusion criteria: 
Known diabetic,known case of chronic pancreatitis ,previous history of  
cholelithiasis,previous history of pancreatic procedures,alcoholics,dyslipidemia 
drug induced pancreatitis. 
  
Study method: 
            This study was approved  by  ethical committee of our institute. 
Patients were selected for the study as per inclusion criteria and exclusion criteria  
mentioned above. Detailed history regarding diabetes mellitus,alcoholism, 
drug abuse, pancreatic procedures, any other pancreatic disorder,gall stone  
 disease have been enquired. Vitals were noted. Basic investigations such as 
total leucocyte count, haematocrit and random blood sugar, were done.Urine 
analysis  was done. Pancreatic enzymes such as amylase and lipase were 
taken into account. Radiodiagnostic studies of  abdomen were done. 
Diagnosis: 
        Was made by history of consumption of OPC poisoning, and clinical  
features  suggestive of OPC and identification of container. 
Leucocytosis: 
      Increase  in number of  WBC  for any type  of  inflammatory reaction. 
Here we observe neutrophilic leucocytosis  more than 10,000  caused by  
pancreatic inflammation  or necrosis. 
random  blood  sugar:  
   hyperglycemia ( >200 mg/l)  is because either  to stress hyperglycemia 
  or  hyperinsulinemia or endocrine insufficiency of pancreas. 
Haematocrit:  >45 suggest haemoconcentration  caused by intravascular volume loss and 
      <35 suggest either blood  loss  due to  Pancreatic necrosis. 
Serum amylase: 
        Considered elevated if > 190 IU/dl , excluding other causes of hyperamylasemia 
Serum lipase: 
    Considered elevated if > 55 IU/dl , and it is more  specific for pancreatic 
Inflammation.. 
All the data are collected meticulously and entered into proforma and master  
chart was prepared. 
 
                
                          
                       
 
 
                                       RESULTS  AND  OBSERVATION 
Statistical  method: 
        Data  were analysed using computer based software by chi-square test. 
p-value < 0.05 was considered as statistically significant. 
Table 5.1:AGE DISTRIBUTION IN STUDY POPULATION: 
  
   
AGE < 190 > 190 
< 30 30 2 
31 TO 40 39 2 
40 TO 50 17 2 
> 50 8 0 
total 94 6 
 
p value 0.929  - not significant 
Inference(Table 5.1): 
consumption  of  OPC is more in middle aged people.That is between 30 to 40  
years of age. 
 Figure 5.1: age distribution in study population 
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 Figure 5.2: prevalence of  hyperamylasemia in study population 
Table 5.2 
 
S.AMYLASE     
< 190 94   
> 190 6 <0.001  Significant 
total 100   
Inference:  OP poison  associated with increase in pancreatic enzyme, amylase   in  6% of 
study population 
94% 
6% 
S.AMYLASE 
< 190 > 190
 Figure 5.3: amylase levels in various age in study population 
Inference: 
            the incidence of  hyper amylasemia is equally distributed  
between  various age groups so it is not statistically significant. 
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Table 5.3: age distribution among study population 
    
AGE < 190 > 190  
< 30 30 2  
31 TO 40 39 2  
40 TO 50 17 2  
> 50 8 0 0.929  Not 
significant 
total 94 6  
 
Inference: 
       Incidence of OPC poisoning is equally distributed among various age  
Groups. 
 
 
 
 Figure 5.4:  sex distribution in study population 
Table 5.3 
    
SEX < 190 > 190  
MALE 73 5  
FEMALE 21 1 0.841  Not 
significant 
total 94 6  
 
 
 
 
78% 
22% 
SEX DISTRIBUTION 
MALE FEMALE
 Inference: 
         OP poisoning is more common among male sex.The prevalence of  
hyperamylasemia  is equal among, male and female sex.. 
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 Figure 5.6: association of amylase with various OP compounds 
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Table 5.4: association of amylase with various OP compounds 
    
COMPOUND < 190 > 190  
diazinon 2 1  
dimethoate 12 0  
malathion 2 0  
monocrotophos 25 0 0.464  Not 
significant 
parathion 1 2  
PHORATE-
10G 
2 1  
propaphenos 27 2  
quinalphos 23 0  
total 94 6  
    
 
 
Inference: 
     There is no significant relation between  various compounds and amylase  
levels. 
 
 Figure: 5.7: association of  amount  and  amylase  levels  
Table 5.6 
    
AMOUNT < 190 > 190  
<5g 28 0 0.411 Not 
significant 
> 5g 66 6  
total 94 6  
Inference: prevalence of  hyperamylasemia is seen only in person who consumed more than 
5grams 
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Figure 5.8 association  of  amylase  and  systolic BP 
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Table 5.7: association  of  amylase and systolic BP 
  
     
  Systolic BP mmHg     
S.AMYLASE mean STD P' 
Value 
 
< 190(94) 127.66 22.83 0.157 Not significant 
> 190(06) 113.33 38.3    
 
Inference:  
       Elevation of amylase is associated with mild decrease in systolic blood  
pressure, but is not significant. 
 
 
 
 
 
 
 Figure 5.9: association of  amylase and  diastolic  BP 
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Table 5.8: association of  amylase  with  diastolic BP 
 
     
  BP mmHg diastolic    
S.AMYLASE mean STD P' 
Value 
 
< 190(94) 78.72 10.1 0.078 Not significant 
> 190(06) 70 20    
     
 
Inference: 
       There  is mild decrease in diastolic blood pressure  in patients  with  
Hyperamylasemia.. 
 
 
 
 
 
 
 Figure 5.10.. association  of  amylase with  pulse rate 
Table 5.10 
     
  PULSE/min      
S.AMYLASE mean SD P' 
Value 
 
< 190(94) 77.03 19.23 0.034 Significant 
> 190(06) 95.17 32.1    
 
Inference:  observation  of  increased  pulse rate  in  hyperamylasemia 
was significant. 
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 Figure 5.11:association  of  amylase  with respiratory rate 
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Table .5.10: association  of  amylase  and  respiratory rate 
   
       
   RR/min < 190 > 190     
11 TO 15 39 1   RR     
16 TO 20 40 1 S.AMYLASE mean STD P' Value 
21 TO 25 13 4 < 190(94) 16.81 3.59 0.027 
26 TO 30 2 0 > 190(06) 20.33 5.13   
total 94 6     
       
       
 
Inference: 
       Increased  respiratory rate  is  associated with hyperamylasemia  was 
 considered significant.. 
 
 
 
 
 
 Figure: 5.12:  association of SPO2 with amylase 
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95 TO 100 59 1 < 190(94) 95.22 2.75 < 0.001 
total 94 6 > 190(06) 90.83 4.02   
 
Table: 5.11:association of  amylase with SPO2 
Inference: 
        Increased prevalence of  decreased  oxygen  saturation  in patients with    
hyperamylasemia.. 
 
 
 
 
 
 
 
 
  
Figure 5.13: association between amylase and ventilatory support 
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Table 5.12: association of  amylase and ventilatory support 
Inference: 
         Increased amylase levels are correlated with  increased  need for ventilator 
        Support. 
 
 
 
 
 
 
 
  
Figure 5.14: association  between leucocyte count with amylase 
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0 TO 10000 48 0  
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Table 5.13: association of  leucocyte count with amylase 
Inference: 
        Leucocytosis is associated  well with OP poisoning.But doesnot correlate 
well with increased amylase level.. 
 
 
 
 Figure 5.15: association  of  haematocrit  with  amylase 
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Significant 
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total 94 6  
 
Table 5.14: association of  amylase with  haematocrit 
Inference: 
         Raised haematocrit associated with increased amylase, more significant    
        as it has 100% association. 
 
 
 
 
 
 Figure 5.16: association  of  blood sugar  with  amylase. 
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RBS < 190 > 190  
< 200 86 4  
> 200 8 2 0.878  Not 
significant 
total 94 6  
 
Table:5.15:association  of  blood sugar   with  amylase 
Inference: 
         Out of 10 patients  with hyperglyemia  2 patients have associated   
increased amylase level, not of much significance 
 
 
 
 
 
 
    
Figure :5.17: association  of   urine sugar  and  amylase 
Inference: 
      Out of   6 patients  with  increased amylase  level only 2% have  
     Glucose  in urine , so it is of  least significance.. 
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Table 5.16:association  of  urine sugar  and amylase  
    
URINE-
SUGAR 
< 190 > 190  
positive 8 2 0.324  Not 
significant 
nil 86 4  
total 94 6  
 
Table 5.17: association  of  urine acetone  with amylase  
    
URINE-
ACETONE 
< 190 > 190  
positive 1 1  
nil 93 5 0.306 Not 
significant 
total 94 6  
 
 Figure 5.18: association  of  amylase  with  lipase 
Table 5.17 
    
S.LIPASE < 190 > 190  
< 55 94 0 0.04 Significant 
> 55 0 6  
total 94 6  
 
Inference: 
     Increase in amylase level correlates parallel with lipase level , suggestive of  
pancreatic inflammation ….   
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 Figure 5.19: relation between amylase and USG-abdomen 
 
 
 
   
 
 
 
 
0
20
40
60
80
100
normal biliary
sludge
edematous
pancreas
fluid
around
pancreas
92 
2 0 0 0 0 3 3 
USG ABDOMEN  VS AMYLASE 
< 190 > 190
Table 5.18: association of  USG-abdomen  and  amylase 
    
USG-
ABDOMEN 
< 190 > 190  
normal 92 0 0.04 Significant 
biliary sludge 2 0  
edematous 
pancreas 
0 3  
fluid around 
pancreas 
0 3  
total 94 6  
 
Inference: 
        Increase in amylase level correlates well with USG  findings suggestive of   
        pancreatic inflammation.. 
 
 
 
 
                                                  
 
                                               DISCUSSION 
In our study the consumption of OPC poisoning is more among males compared to females 
 pancreatic enzymes such as amylase, lipase  are  compared  with variables such as age, sex, 
amount, vitals, need for ventilatory support, random blood sugar, leucocyte count, 
haematocrit… 
This study is to emphasise the importance of diagnosing pancreatitis in 
unexplained hypotension or shock  in  OPC excluding other causes also whether  
the blood sugar elevation correlates with elevation of amylase, suggesting  
pancreatitis  is  also   the cause for hyperglycemia  other than  stress  
hyperglycemia caused by release of stress hormones such as catecholamines 
which is induced by hyperinsulinemia that occurs during cholinergic phase… 
paradoxically, studies shows that hypoglycaemia can also occur that cause seizure 
 leading to diagnostic confusion. 
         As per Dressel and colleagues experiment  OPC induced pancreatitis is  
secondary to functional duct obstruction   and stimulated exocrine secretion 
In that study   hyperglycemia is found in only 7% and  glycosuria in 14% .But 
in our study hyperglycemia is seen in 10%  along with  glycosuria. 
Ketones are found in urine in only 2% , of which 1% is due to starvation ketosis 
Remaining 1% is due to  hyperglycemic ketoacidosis that present as DKA… 
Among the 10% of  hyperglycemics , only 2% have evidence of  pancreatic  
Inflammation… pancreatic enzymes are elevated in 6% of the study population 
Of which only 2%   have  hyperglycemia which is caused by pancreatic endocrine  
Insufficiency. 
In our study all the 6% of study population  have evidence of dehydration and  
Hemoconcentration  evidenced by raised haematocrit which has to be followed up  
Serially. In any series of study in poisoning and as per our study incidence of OPC poisoning  
is common among middle aged- men.As per our study, type of compound, amount of  
compound, doesnot predicted by amylase level.Systolic and diastolic BP  does not correlates 
 with amylase level in significant manner, except mild decrease in systolic or diastolic BP 
Tachycardia in OP poison correlates well with amylase level. In our study  
study population with amylase > 190 have pulse rate  of mean around 95/min. 
 Respiratory rate if increased  is associated with statistically significant  
increase in amylase level. In our study among 6 patients  with  
hyperamylasemia, 4 patients have increased respiratory rate.Further decreased 
oxygen saturation  have good association with amylase level thus the need for  
ventilatory  support.In our study out of  6 patients having amylase >190 IU/L 
4 patients have decreased SPO2 in range of 85 to 90%.. 
5 out  of  6 patients needs ventilator support who have evidence of pancreatic  
Inflammation…leucocyte count is increased in OPC poisoning irrespective of rise in 
 serum amylase.Finally serum lipase  increases parallely with amylase  
suggesting that other causes of hyperamylasemia are  ruled out. 
A total of 47 patients were studied in a teaching hospital in Yuzuncu yoi  
university  of which  4 patients have elevated amylase and lipase level around  
300U/L and 60U/L…Among patients  in which amylase levels between 100-300 U/L   
Only 2 patients have elevated lipase level, as assessed  by calorimetric method.. 
 
 
 
 
 
 
 
 
                                                    
 
                                                CONCLUSION:   
As per  our study incidence of pancreatitis is 6% among OPC poisoning 
It is evidenced by increase in serum amylase and lipase , supported by  
leucocytosis, increased  haematocrit.,USG  evidence  of  pancreatic  
inflammation  and statistically significant…. 
The incidence of hyperglycemia is 10%  among OPC poisoning  
with  equal  Incidence of  glycosuria  ... 
Relation   between  blood sugar  and pancreatic enzymes in controversial… 
out of  6 patients with hyperamylasemia only 2 patients have hyperglycemia.. 
whether it is due to pancreatitis or stress induced  is not known and it is not  
statistically significant. 
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                                             ABBREVIATION 
 
OPC              -----      organophosphorus compound 
AChE           -----       acetylcholinesrerase 
BAEM         -----       British association of emergency medicine 
CFTR          -----        cystic fibrosis transmembrane regulator 
CCK            -----        cholecystokinin 
NTE            -----        neuropathy target enterase 
OPIDN       -----         organophosphorus induced delayed neuropathy 
SWS           -----         swiss cheese protein 
PSP            -----          phenyl salygenin phosphate 
Hup-A       -----           Huperzine-A 
MAP          -----         mitogen activated protein 
DFP          -----          Diisopropylphosphorofluoridate 
PTEs         -----          phosphotriesterase 
TLC         -----           thin layer chromatography 
GABA     -----           gamma amino butyric acid            
 
 
 
  
 
 
                                            PROFORMA 
NAME:                                                           AGE:                       SEX:             DATE: 
PRESENTING COMPLAINTS: 
PAST HISTORY:  
H/O  CHRONIC PANCREATITIS/ PANCREATIC PROCEDURES / ALCOHOLISM / DRUG INTAKE / 
DM 
GENERAL EXAMINATION: 
VENTILATORY SUPPORT: YES / NO 
IF YES, VENTILATORY SETTINGS: 
 
VITALS:   PULSE:    BP:   RESPIRATORY.RATE:     SpO2:  
SYSTEM EXAMINATION: 
CVS: 
RS: 
ABD: 
CNS:    
INVESTIGATIONS: 
TOTAL LEUCOCYTE COUNT: 
CASUAL BLOOD SUGAR:              SERUM. AMYLASE:            SERUM.LIPASE:           
URINE ACETONE:                          URINE SUGAR:                   PCV:                   
 USG-ABDOMEN: 
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